Showing results (641-650 of 711) with videos related to
Sort By:
Pageof 72
Journal of Clinical Epidemiology|May 11, 2025
Randomization procedures in parallel-arm cluster randomized trials in low- and middle-income countries: a review of 300 trials published between 2017 and 2022Julia F Shaw, Cory E Goldstein, Thais Mazzetti, et al.BMJ Open|September 17, 2024
Systematic scoping review of cluster randomised trials conducted exclusively in low-income and middle-income countries between 2017 and 2022Cory E Goldstein, Yacine Marouf, Mira Johri, et al.Nature Metabolism|January 19, 2021
No evidence for brown adipose tissue activation after creatine supplementation in adult vegetariansNiels J Connell, Daniel Doligkeit, Charlotte Andriessen, et al.BMC Medical Ethics|November 22, 2018
Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocolStuart G Nicholls, Kelly Carroll, Jamie Brehaut, et al.Disease Markers|March 28, 2018
Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment ResponseMaikel Verduin, Inge Compter, Danny Steijvers, et al.Nuclear Medicine Communications|February 26, 2026
The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PETMelissa Lenaerts, Lois van der Voort, Marjolein L Smidt, et al.Transplantation|March 19, 2024
Developing Guidance for Donor Intervention Randomized Controlled Trials: Initial Discussions From the Canada-United Kingdom 2022 WorkshopMarat Slessarev, Katie L Bain, John Basmaji, et al.The Journal of Clinical Investigation|May 22, 2018
The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia modelMarina García-Peydró, Patricia Fuentes, Marta Mosquera, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemiaJudith Branger, Bernt van den Blink, Sebastiaan Weijer, et al.Blood|June 7, 2003
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant miceRozemarijn S van Rijn, Elles R Simonetti, Anton Hagenbeek, et al.Pageof 72